Medical Affairs Consulting for Pharma and Biotech
In brief
What does Medical Affairs consulting provide?
It helps companies establish, scale or refocus Medical Affairs so evidence, scientific exchange and stakeholder insight improve clinical, launch, access and lifecycle decisions.
- Best suited to
- Companies maturing toward launch, affiliates needing senior medical capacity, or teams whose Medical Affairs work has become reactive or fragmented.
- Typical scope
- Mandate, priorities, governance, evidence gaps, scientific exchange, stakeholder insight, launch readiness and team capability.
- Expected outcome
- A practical Medical Affairs model that strengthens external confidence, internal decisions and long-term product value.
Expert lead: Mogens Gisselbaek, MD, MSc, physician executive and founder of Gisselbaek Consulting.
Medical Affairs support that turns evidence, scientific exchange and stakeholder engagement into lifecycle value.
Gisselbaek Consulting helps companies establish, scale or refocus Medical Affairs so that the function is aligned with clinical development, launch readiness, market access, commercial strategy and long-term evidence generation. Support is relevant at headquarters, regional and affiliate level across the Nordics, Europe and the UK.
When this support is most useful
This is often relevant when a development-stage company is maturing into a launch organisation; a specialty-pharma affiliate needs senior medical capacity; Medical Affairs has become reactive or fragmented; or leaders need a practical plan that connects evidence, stakeholder insight, access and adoption.
What changes
The aim is to move Medical Affairs from an activity list or late-stage review function to a strategic contributor to evidence, external confidence and internal decision-making. This includes clarifying mandate, priorities, governance, evidence gaps, scientific exchange and the development of people and capability.
Typical scope
- Medical Affairs strategy and operating model design.
- KOL engagement, advisory board and scientific exchange planning.
- Evidence generation, publication and congress planning.
- MSL strategy, field medical priorities and team mentoring.
- Medical-commercial governance and compliant review processes.
Relevant situations
- Preparing for launch or geographic expansion.
- Building Medical Affairs after a development-stage company begins to mature.
- Repositioning Medical Affairs from support function to strategic value driver.
- Creating medical plans that connect evidence, trust, access and adoption.
Recent Medical Affairs assignment
Gisselbaek Consulting is currently supporting Abacus Medicine Pharmaceuticals in a fractional Medical Affairs consulting assignment, established in collaboration with Brice Group. The engagement combines senior medical-strategy input with hands-on execution.
Discuss Medical Affairs consulting support.
View all five Core Services. Related service: Fractional Senior Medical Leadership.